Coronary heart disease. New guidelines of the European Society of Atherosclerosis for prevention
Heinzl, S.
Medizinische Monatsschrift für Pharmazeuten 16(7): 210-213
1993
ISSN/ISBN: 0342-9601 PMID: 8366843 Document Number: 417986
Document emailed within 1 workday
Related Documents
Pyörälä, K.; de Backer, G.; Graham, I.; Poole-Wilson, P.; Wood, D. 1995: Prevention of coronary disease in clinical practice. Guidelines of the working group of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension Archives des maladies du coeur et des vaisseaux 88(10 Suppl): 1493-1542Gohlke-Bärwolf, C.; Acar, J.; Oakley, C.; Butchart, E.; Burckhart, D.; Bodnar, E.; Hall, R.; Delahaye, J.P.; Horstkotte, D.; Krémer, R. 1995: Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology European Heart Journal 16(10): 1320-1330
Athyros, V.G.; Mikhailidis, D.P.; Papageorgiou, A.A.; Mercouris, B.R.; Athyrou, V.V.; Symeonidis, A.N.; Basayannis, E.O.; Demitriadis, D.S.; Kontopoulos, A.G. 2002: Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study Current medical research and opinion 18(8): 499-502
Ho, K.K.Y. 2007: Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia European journal of endocrinology 157(6): 695-700
Sandoe, J.A.T.; Barlow, G.; Chambers, J.B.; Gammage, M.; Guleri, A.; Howard, P.; Olson, E.; Perry, J.D.; Prendergast, B.D.; Spry, M.J.; Steeds, R.P.; Tayebjee, M.H.; Watkin, R. 2015: Guidelines for the diagnosis, prevention and management of implantable cardiac electronic device infection. Report of a joint Working Party project on behalf of the British Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society (BHVS) and British Society for Echocardiography (BSE) Journal of antimicrobial chemotherapy 70(2): 325-359
Koletzko, B.; Goulet, O.; Hunt, J.; Krohn, K.; Shamir, R. 2005: Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR) Journal of Pediatric Gastroenterology and Nutrition 41(Suppl 2): S1-S87
Bubnova, M.G. 2004: Atorvastatin: lipid lowering activity, pleiotropic properties and efficacy in prevention of atherosclerosis and coronary heart disease Kardiologiia 44(8): 96-104
2003: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension Journal of Hypertension 21(6): 1011-1053
Hwang, S.J.; Ballantyne, C.M.; Sharrett, A.R.; Smith, L.C.; Davis, C.E.; Gotto, A.M.; Boerwinkle, E. 1997: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study Circulation 96(12): 4219-4225
Lu, G.; Xu, Z.-W.; Zhang, Y.-L.; Yang, Z.-J.; Zhang, X.-L.; Yin, K.-S. 2007: Correlation among obstructive sleep apnea syndrome, coronary atherosclerosis and coronary heart disease Chinese Medical Journal 120(18): 1632-1634
Mera, S.L. 1993: Atherosclerosis and coronary heart disease British Journal of Biomedical Science 50(3): 235-248
Ball, M.J. 1987: The aetiology of atherosclerosis and coronary heart disease British Journal of Hospital Medicine 38(5): 404-410
Masur, H.; Brooks, J.T.; Benson, C.A.; Holmes, K.K.; Pau, A.K.; Kaplan, J.E. 2014: Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 58(9): 1308-1311
2000: 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part III. Prevention of disease recurrence. United States Public Health Service/Infectious Diseases Society of America American Family Physician 61(3): 771-8 780 785
Kittel, F.; Kornitzer, M.; De Backer, G.; Dramaix, M. 1982: The Belgian Heart Disease Prevention Project: type A behavior pattern and the prevalence of coronary heart disease Activitas Nervosa Superior Suppl. 3(Pt 1): 78-83
Amouyel, P.; Montaye, M. 1998: Management of risk factors after coronary heart disease in European countries Revue d'Epidemiologie et de Sante Publique 46(6): 497-507
Lupanov, V.P.; Chotchaev, K.K.; Evstifeeva, S.E.; Deev, A.D.; Naumov, V.G. 2002: Clinical course of disease and prognosis in patients with ischemic heart disease with stable angina pectoris, caused by stenosing coronary atherosclerosis (data from a a 20-year study Terapevticheskii Arkhiv 74(9): 13-20
O'Dwyer, C.; Hade, D.; Fan, C.W.; Cunningham, C.; Kenny, R.A. 2010: How well are European Society of Cardiology (ESC) guidelines adhered to in patients with syncope? Irish Medical Journal 103(1): 11-14
Gohlke, H.; Kübler, W.; Mathes, P.; Meinertz, T.; Schuler, G.; Gysan, D.B.; Sauer, G. 2001: Recommendations for an extensive risk decrease for patients with coronary disease, vascular diseases and diabetes. Issued by the Executive Committee of the German Society of Cardiology, Heart and Circulation Research, reviewed on behalf of the Clinical Cardiology Commission by the Prevention Project Group Zeitschrift für Kardiologie 90(2): 148-149
Kotel'nikova, E.V.; Gridnev, V.I.; Dobgalevskiĭ, P.Ia.; Bespiatov, A.B. 2004: Prognostication of coronary atherosclerosis for selection of tactics of management of patients with ischemic heart disease Kardiologiia 44(3): 15-19